Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

(+)-Theta-cypermethrin

Copy Product Info
🥰Excellent

Synonyms:

Catalog No. T219197 Copy Product Info
🥰Excellent
(+)-Theta-cypermethrin is a stereoisomer of Cypermethrin that can penetrate the blood-brain barrier and exhibits high affinity binding with AKT1, SRC, STAT3, and EGFR. It reduces delayed rectifier potassium channel current amplitude, causing a shift in the steady-state activation curve toward more negative potentials. At higher concentrations, it also shifts the steady-state inactivation curve negatively. Additionally, (+)-Theta-cypermethrin can induce abnormal electrical activity in rat hippocampal neurons and is associated with chronic respiratory system damage and neurotoxicity.


(+)-Theta-cypermethrin

Cas No. 65732-07-2
Pack SizePriceUSA StockGlobal StockQuantity
10 mgInquiry10-14 weeks10-14 weeks
50 mgInquiry10-14 weeks10-14 weeks
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
(+)-Theta-cypermethrin is a stereoisomer of Cypermethrin that can penetrate the blood-brain barrier and exhibits high affinity binding with AKT1, SRC, STAT3, and EGFR. It reduces delayed rectifier potassium channel current amplitude, causing a shift in the steady-state activation curve toward more negative potentials. At higher concentrations, it also shifts the steady-state inactivation curve negatively. Additionally, (+)-Theta-cypermethrin can induce abnormal electrical activity in rat hippocampal neurons and is associated with chronic respiratory system damage and neurotoxicity.
In vitro
(+)-Theta-cypermethrin, when applied via perfusion at concentrations ranging from 1 to 100 nM during electrophysiological recording, can inhibit the delayed rectifier potassium current (I k) in rat hippocampal CA3 neurons in a concentration-dependent manner in vitro. At a concentration of 100 nM, it can reduce the amplitude of I k by up to 53.28%, shift the steady-state activation and inactivation curves towards more negative potentials, and decrease the slope factor of the activation curve.
Chemical Properties
Molecular Weight416.30
FormulaC22H19Cl2NO3
Cas No.65732-07-2
SmilesC(O[C@H](C#N)C1=CC(OC2=CC=CC=C2)=CC=C1)(=O)[C@@H]3[C@@H](C=C(Cl)Cl)C3(C)C
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 µL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 µL Tween 80 and mix well until fully clarified.

3) Add 450 µL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
µL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: (+)-Theta-cypermethrin in vitro | (+)-Theta-cypermethrin formula | (+)-Theta-cypermethrin molecular weight